SCHEMBL20685774

SCHEMBL20685774

CC(C)[C@@H](C)Nc1ccnc(Cl)n1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 9/20 0.42
▸ NR4A2 P43354 2/20 0.41
▸ HCAR3 P49019 1/20 0.40
▸ CSF1R P07333 1/20 0.35
▸ LTK P29376 1/20 0.35
▸ MAPK8 P45983 1/20 0.35
▸ MAPK9 P45984 1/20 0.35
▸ CDK7 P50613 1/20 0.35
▸ CDK9 P50750 1/20 0.35
▸ RPS6KA3 P51812 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ PTK2 Q05397 1/20 0.35
▸ CAMK1D Q8IU85 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ ALK Q9UM73 1/20 0.35
▸ DYRK1B Q9Y463 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ PLK1 P53350 2/20 0.35
▸ GRM5 P41594 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1774897 0.86 GAA (0.42) MAPK14NR4A2HCAR3CSF1RMAPK8
SCHEMBL21550282 0.85 ESR1 (0.35) MAPK14NR4A2ESR1PLK1GRM5
SCHEMBL5756104 0.83 GRM5 (0.36) MAPK14ESR1GRM5
SCHEMBL20911283 0.81 NR4A2 (0.34) MAPK14NR4A2ESR1PLK1GRM5
SCHEMBL19402115 0.81 NR4A2 (0.34) MAPK14NR4A2ESR1PLK1GRM5
SCHEMBL11306797 0.80 CCR4 (0.34) CLK4ESR1GRM5
SCHEMBL20612065 0.80 HCAR3 (0.43) MAPK14HCAR3ESR1
SCHEMBL28277650 0.80 HCAR3 (0.43) MAPK14HCAR3ESR1
SCHEMBL20991790 0.80 CFD (0.33) NR4A2ESR1PLK1GRM5
SCHEMBL19402117 0.80 MAPK9 (0.34) NR4A2MAPK9ESR1PLK1GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3434674-A1 COMPOUND HAVING MUTANT IDH INHIBITORY ACTIVITY, PREPARATION METHOD AND USE THEREOF Shanghai Haihe Pharmaceutical Co., Ltd. (CN) 2019-01-30 — — EP disclosed
Send feedback